4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-19-019895
President & CEO sold 24,412 shares at $99.39 ($2,426,309)
- President & CEO acquired 53,654 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Simon, Christopher · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-22 | Grant or award : show line 1 in the form | +53,654 | 274,645 | D | ||
| 2019-05-23 | Sale : show line 2 in the form | −24,412 | $99.39 | $2,426,309 | 250,233 | D |
| Open-market sales · 24,412 sh · avg $99.39 · $2,426,309 | ||||||
Loading xslF345X03/form4.xml…